| 1、Lixin Pharmaceutical was approved by U.S. Food and Drug Administration (FDA) in 2010, and had a review with zero defect in 2015. |  |
2、Lixin Pharmaceutical was approved by European Directorate for the Quality of Medicines (EDQM), European Medicines Agency (EMA) in Oct, 2016.
 |  |  |
| Hydrochlorothiazide-CEP-certificate | Dacarbazine-CEP-certificate | Indapamide-CEP-certificate |
 |  |  |
Chinese
English